The reduced Ki‐67 expression in xenograft tumours of LY294002‐treated mice also implied that PI3K/AKT signalling inhibition had the ability to counteract the MRPS16 influence on enhancing cell proliferation (Figure S3D). The gene discussed is AKT1; the disease is neoplasm.